Related Experiment Video
Updated: Feb 16, 2026

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
Published on: June 12, 2018
miR-155 in cancer drug resistance and as target for miRNA-based therapeutics
Recep Bayraktar1, Katrien Van Roosbroeck2
1Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1881 Holcombe Boulevard, Unit 1950, Houston, TX, 77054, USA.
Abstract:
Small non-coding microRNAs (miRNAs) are instrumental in physiological processes, such as proliferation, cell cycle, apoptosis, and differentiation, processes which are often disrupted in diseases like cancer. miR-155 is one of the best conserved and multifunctional miRNAs, which is mainly characterized by overexpression in multiple diseases including malignant tumors. Altered expression of miR-155 is found to be associated with various physiological and pathological processes, including hematopoietic lineage differentiation, immune response, inflammation, and tumorigenesis. Furthermore, miR-155 drives therapy resistance mechanisms in various tumor types. Therefore, miR-155-mediated signaling pathways became a potential target for the molecular treatment of cancer. In this review, we summarize the current findings of miR-155 in hematopoietic lineage differentiation, the immune response, inflammation, and cancer therapy resistance. Furthermore, we discuss the potential of miR-155-based therapeutic approaches for the treatment of cancer.
Insights
MicroRNAs (miRNAs) regulate cell processes, with miR-155 linked to cancer and therapy resistance. Targeting miR-155 offers potential for novel cancer treatments.
Area of Science:
- Molecular Biology
- Oncology
- Immunology
Background:
- MicroRNAs (miRNAs) are key regulators of cellular functions, including proliferation and apoptosis.
- Dysregulated miRNA expression is implicated in various diseases, notably cancer.
- miR-155 is a conserved, multifunctional miRNA frequently overexpressed in malignant tumors.
Purpose of the Study:
- To review the role of miR-155 in hematopoietic differentiation, immune response, and inflammation.
- To explore miR-155's involvement in cancer therapy resistance.
- To discuss the therapeutic potential of targeting miR-155 in cancer treatment.
Main Methods:
- Literature review of studies on miR-155 function and its clinical relevance.
- Analysis of miR-155's impact on cellular processes and disease pathogenesis.
- Synthesis of current knowledge on miR-155-mediated signaling pathways.
Main Results:
- miR-155 is associated with hematopoietic lineage differentiation, immune regulation, and inflammatory processes.
- Overexpression of miR-155 contributes to tumorigenesis and drives therapy resistance in various cancers.
- miR-155 plays a significant role in the complex interplay between immunity, inflammation, and cancer development.
Conclusions:
- miR-155 is a critical regulator in physiological and pathological processes, particularly in cancer.
- Understanding miR-155's functions is crucial for developing targeted cancer therapies.
- miR-155-based strategies hold promise for overcoming cancer therapy resistance and improving patient outcomes.
More Related Videos
11:56Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Treatment Resistant Cancers
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring: Affecting Factors
Targeted Cancer Therapies
There are several types of targeted therapies against...